"Bromocriptine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.
| Descriptor ID |
D001971
|
| MeSH Number(s) |
D03.132.327.412.100 D03.633.400.439.131 D03.633.400.562.100
|
| Concept/Terms |
Bromocriptine- Bromocriptine
- 2-Bromo-alpha-ergokryptine
- 2 Bromo alpha ergokryptine
- Bromocryptin
- 2-Bromoergokryptine
- 2 Bromoergokryptine
- Bromocriptin
- 2-Bromoergocryptine
- 2 Bromoergocryptine
- 2-Bromo-alpha-ergocryptine
- 2 Bromo alpha ergocryptine
2-Bromoergocryptine Mesylate- 2-Bromoergocryptine Mesylate
- 2 Bromoergocryptine Mesylate
- Mesylate, 2-Bromoergocryptine
- Bromocriptine Mesylate
- Mesylate, Bromocriptine
- 2-Bromoergocryptine Methanesulfonate
- 2 Bromoergocryptine Methanesulfonate
- Methanesulfonate, 2-Bromoergocryptine
|
Below are MeSH descriptors whose meaning is more general than "Bromocriptine".
Below are MeSH descriptors whose meaning is more specific than "Bromocriptine".
This graph shows the total number of publications written about "Bromocriptine" by people in this website by year, and whether "Bromocriptine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bromocriptine" by people in Profiles.
-
Billups J, Jones C, Jackson TL, Ablordeppey SY, Spencer SD. Simultaneous RP-HPLC-DAD quantification of bromocriptine, haloperidol and its diazepane structural analog in rat plasma with droperidol as internal standard for application to drug-interaction pharmacokinetics. Biomed Chromatogr. 2010 Jul; 24(7):699-705.
-
Francia G, Dav? MV, Montresor E, Colato C, Ferdeghini M, Lo Cascio V. Long-term quiescence of ectopic Cushing's syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: spontaneous remission or therapeutic effect of bromocriptine? J Endocrinol Invest. 2006 Apr; 29(4):358-62.
-
Peeva E, Grimaldi C, Spatz L, Diamond B. Bromocriptine restores tolerance in estrogen-treated mice. J Clin Invest. 2000 Dec; 106(11):1373-9.
-
Mueller PS. Neuroleptic malignant syndrome. Psychosomatics. 1985 Aug; 26(8):654-62.
-
Thordarson G, Forsyth IA. Dopamine reduces the receptor binding activity and not the secretion rate of placental lactogen in vitro. J Reprod Fertil. 1984 Nov; 72(2):261-7.
-
Mueller PS, Vester JW, Fermaglich J. Neuroleptic malignant syndrome. Successful treatment with bromocriptine. JAMA. 1983 Jan 21; 249(3):386-8.